1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 35 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2009Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRMI) and opioid defendence: A meta-analysisColler, J.; Beardsley, J.; Bignold, J.; Li, Y.; Merg, F.; Sullivan, T.; Cox, T.; Somogyi, A.
2004A new simple diagnostic assay for the identification of the major CYP2D6 genotypes by DNA sequencing analysisJames, H.; Coller, J.; Gillis, D.; Bahnisch, J.; Sallustio, B.; Somogyi, A.
2007Pharmacogenetics of opioidsSomogyi, A.; Barratt, D.; Coller, J.
2008Pharmacogenomics and PharmacogeneticsSomogyi, A.; Coller, J.
2003Relationship between CYP2D6 genotype and plasma OH-perhexiline/perhexiline concentration ratio in angina patients.Sallustio, B.; Davies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.
2004CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomesHutchinson, M.; Menelaou, A.; Foster, D.; Coller, J.; Somogyi, A.
2006Association between the DRD2 A(1) allele and response to methadone and buprenorphine maintenance treatmentsBarratt, D.; Coller, J.; Somogyi, A.
2007Lack of influence of CYP2D6 genotype on the clearance of (R)- (S)- and racemic-methadonColler, J.; Joergensen, C.; Foster, D.; James, H.; Gillis, D.; Christrup, L.; Somogyi, A.
2014Pharmacogenomics of methadone maintenance treatmentSomogyi, A.; Barratt, D.; Ali, R.; Coller, J.
2018CYP3A5*3 and ABCB1 61A>G significantly influence dose-adjusted trough blood tacrolimus concentrations in the first three months post-kidney transplantationHu, R.; Barratt, D.; Coller, J.; Sallustio, B.; Somogyi, A.

Discover